Browsing Category

Supplier News

195 posts

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

News from DCAT Week 2022: HAS Healthcare Advanced Synthesis Outlines Multi-Year Expansion Plan
By

By
HAS Healthcare Advanced Synthesis (formerly Helsinn Advanced Synthesis), which launched as an independent business earlier this year (2022), is proceeding with a multi-year CHF 100-million-plus ($108-million) investment plan to expand…

News from DCAT Week 2022: AGC Biologics CEO Outlines $1.6-Bn Expansion Plan
By

By
Patricio Massera, CEO, AGC Biologics, a biologics CDMO, outlined a $1.6-billion expansion plan over the next four years in its global biomanufacturing network at the DCAT Member Company Announcement Forum…

News from DCAT Week 2022: CordenPharma Acquires Three Drug-Product Mfg Facilities
By

By
CordenPharma has added to its drug-product manufacturing with the acquisition of three facilities from Vifor Pharma, a Saint Gallen, Switzerland-headquartered specialty pharmaceutical company. Dr. Stephen Houldsworth, Vice President, Global Head…

News from DCAT Week 2022: Lonza Highlights Major Biomanufacturing Expansions
By

By
Lonza is proceeding with major expansions in its global biomanufacturing manufacturing network as wel as with targeted investment in parenteral drug-product manufacturing. Jean-Christophe Hyvert, President of Lonza’s Biologics and Cell…

News from DCAT Week 2022: Cambrex CEO Announces $100 M for Small-Molecule API Expansions
By

By
Thomas Loewald, CEO, Cambrex, announced an expansion of more than $100 million across its global manufacturing network for small-molecule active pharmaceutical ingredients (APIs) at the DCAT Member Company Announcement Forum…

News from DCAT Week 2022: Catalent Integrates $1-Billion Acquisition of Bettera; Other Updates
By

By
Karen Flynn, Chief Commercial Officer, Catalent, highlighted a $1.3-billion global expansion plan, which included the $1-billion acquisition of Bettera, a manufacturer of consumer healthcare products, at the DCAT Member Company…

News from DCAT Week 2022: Samsung Biologics Highlights Major Biomanufacturing Expansions
By

By
Samsung Biologics, a Songdo, Incheon, Korea-based contract biologics manufacturer, is moving ahead with major biomanufacturing expansions: a new multi-modal facility, addition of mRNA capacity, and a new large-scale biomanufacturing plant.…

News from DCAT Week 2022: Cytiva Provides Update of $1.5-Bn Bioprocessing Expansion Plan
By

By
Mary Blenn, Vice President, Global Supply Chain, Cytiva, a supplier of products to support bioprocessing, provided an update of a $1.5-billion expansion plan at the DCAT Member Company Announcement Forum…

News from DCAT Week 2022: Thermo Fisher Investing in Advanced Therapies, Biologics and Sterile Mfg
By

By
Leon Wyszkowski, President of Commercial Operations, Pharma Services, Thermo Fisher Scientific, provided updates of several key investments to expand the company’s global capacity and capabilities at the DCAT Member Company…

News from DCAT Week 2022: WuXi STA Outlines Major Expansion Plans
By

By
WuXi STA, a subsidiary of WuXi AppTec, is proceeding with a major expansion plan in its global R&D and manufacturing network for small-molecule active pharmaceutical ingredients (APIs), oligonucleotides, peptides, and…